Bharat Parenterals Limited (BPLPHARMA)

BSE: ₹1,380.00
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 69.91 59.81 59.82 67.82 92.51 71.63 72.26 103.98 116.00 64.62 65.19 99.62
YOY Revenue Growth % 167.96% -26.97% 1.36% 33.06% 32.33% 19.76% 20.8% 53.32% 25.39% -9.79% -9.79% -4.19%
Other Income 2.10 2.60 1.26 2.64 2.54 4.21 2.95 2.20 1.06 3.53 1.33 3.63
Total Income 72.01 62.41 61.08 70.46 95.05 75.84 75.21 106.18 117.06 68.15 66.52 103.25
Total Expenses + 61.93 57.87 55.61 71.82 99.82 91.22 80.71 114.48 114.52 75.47 74.80 111.62
Cost of Materials Consumed 46.13 29.61 49.67 47.75 54.80 26.94 45.25 51.18 54.83 31.41 26.11 51.35
Employee Benefit Expense 4.98 5.86 5.31 6.64 9.92 10.62 10.98 18.14 15.30 16.49 17.03 18.46
Other Expenses 14.01 12.41 11.27 16.14 23.53 26.98 21.97 30.06 18.08 20.39 14.11 23.94
Operating Profit 7.98 1.94 4.21 -4.00 -7.31 -19.59 -8.45 -10.50 1.48 -10.85 -9.61 -12.00
OPM % 11.4% 3.2% 7% -5.9% -7.9% -27.3% -11.7% -10.1% 1.3% -16.8% -14.7% -12%
Profit Before Tax + 10.08 4.54 5.47 -1.36 -4.77 -15.38 -5.50 -8.30 2.54 -7.32 -8.28 -8.37
Tax Expense 10.08 2.11 1.83 1.20 4.08 2.14 2.37 1.14 3.41 1.29 1.39 -0.21
Tax % 100% 46.5% 33.5% - - - - - 134.3% - - -
Profit After Tax 0.00 2.43 3.64 -2.56 -8.85 -17.52 -7.87 -9.44 -0.87 -8.61 -9.67 -8.16
EPS (Basic) 13.03 6.07 6.45 -0.62 -14.71 -27.00 -10.00 -14.40 -1.27 -14.00 -14.03 -11.84

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 345.43 340.38 257.36 217.98 212.01 204.64
YOY Revenue Growth % 1.48% 32.26% 18.07% 2.82% 3.6% -
Other Income 9.54 11.90 8.59 11.74 7.78 8.68
Total Income 354.98 352.28 265.95 229.72 219.79 213.32
Total Expenses + 376.40 386.23 247.23 206.17 191.91 186.20
Cost of Materials Consumed 169.26 178.17 173.16 146.07 132.72 127.13
Employee Benefit Expense 67.28 49.66 22.78 18.00 15.37 14.75
Other Expenses 70.94 102.54 53.85 42.62 32.93 30.39
Operating Profit -30.97 -45.85 10.13 11.81 20.10 18.44
OPM % -9% -13.5% 3.9% 5.4% 9.5% 9%
Profit Before Exceptional -21.42 -33.95 18.72 23.55 27.88 27.12
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + -21.42 -33.95 18.72 23.55 27.88 27.12
Tax Expense 5.88 9.73 8.20 7.83 7.07 6.81
Tax % - - 43.8% 33.2% 25.4% 25.1%
Profit After Tax -27.31 -43.68 10.52 15.72 20.81 20.31
EPS (Basic) -39.62 -66.64 8.65 28.40 36.67 35.59

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 300.26 292.50 243.90 166.06 82.32 50.62
Property, Plant & Equipment 201.60 198.88 209.48 41.19 39.75 43.36
Capital Work in Progress 33.95 30.22 23.89 99.01 25.65 0.44
Non-Current Investments 1.10 0.00 0.00 0.00 0.00 0.00
Goodwill 52.10 52.10 0.00 0.00 0.00 0.00
Other Intangible Assets 0.24 0.13 0.00 0.00 0.00 0.00
Current Assets + 313.04 356.03 259.91 184.28 143.74 148.03
Inventories 84.72 71.95 61.47 37.84 20.76 22.43
Trade Receivables 150.65 171.74 141.42 112.41 73.40 67.83
Cash and Cash Equivalents 1.48 0.56 8.71 7.85 3.40 1.68
Current Investments 5.00 4.98 0.00 0.00 11.48 42.79
LIABILITIES & EQUITY
Total Equity 311.58 339.00 238.18 217.89 170.14 143.82
Equity Share Capital 6.89 6.89 5.82 5.77 5.77 5.73
Other Equity 315.34 323.78 191.45 177.02 160.05 138.09
Non-Current Liabilities 144.32 90.23 75.26 12.65 14.39 11.20
Current Liabilities 157.39 219.30 190.37 119.80 41.53 43.63
Total Liabilities 301.72 309.53 265.63 132.45 55.92 54.83

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities 38.36 -14.39 -4.71 21.66 -1.07 31.25
Cash from Investing Activities 9.32 -137.12 -104.78 -77.82 -6.63 -47.94
Cash from Financing Activities -47.05 156.09 110.43 60.60 9.42 8.27
Net Increase/Decrease in Cash 0.64 4.46 0.94 4.44 1.72 -8.42